Zepbound dosing: dosage chart, schedule, and refill guide

12 min read

Share

A cream felt desk calendar with coral binding and a navy square.

TL;DR

Zepbound is injected once weekly. The usual Zepbound dosing schedule starts at 2.5 mg for four weeks, followed by 5 mg if the prescriber considers an increase appropriate. Later increases are generally made in 2.5 mg steps after at least four weeks at the current dose. An increase is permitted, not automatic. We recommend using the lowest labeled maintenance dose that supports treatment goals without causing side effects that outweigh its benefits.

Zepbound dosage chart and weekly schedule

Zepbound dosage chart and weekly schedule

Zepbound is injected once weekly. Treatment usually starts at 2.5 mg for four weeks. The next labeled strength is 5 mg once weekly if the prescriber decides an increase is appropriate.

A refill date may coincide with the earliest time an increase is permitted. That does not mean the dose must rise. Current symptoms, appetite changes, weight trends, treatment goals, and time at the present dose all matter.

DoseEarliest typical timingRoleWeight-management maintenance dose?
2.5 mg once weeklyWeeks 1–4Starting doseNo
5 mg once weeklyAfter four weeks at 2.5 mgFirst maintenance optionYes
7.5 mg once weeklyAfter at least four weeks at 5 mgEscalation stepNo
10 mg once weeklyAfter at least four weeks at 7.5 mgMaintenance optionYes
12.5 mg once weeklyAfter at least four weeks at 10 mgEscalation stepNo
15 mg once weeklyAfter at least four weeks at 12.5 mgMaintenance option and maximum doseYes

The current prescribing instructions use 2.5 mg increases, with at least four weeks at a dose before another increase. For weight management, the labeled maintenance options are 5 mg, 10 mg, or 15 mg once weekly. The appropriate dose depends on response and tolerability.

Starting dose: 2.5 mg once weekly

The 2.5 mg dose introduces the body to tirzepatide. It is a starting dose rather than a maintenance dose.

After four completed weeks, the clinician may prescribe 5 mg. Before recommending that change, we suggest reporting nausea, constipation, diarrhea, vomiting, food and fluid intake, missed injections, and any other symptoms. These details help the clinician decide whether an increase is suitable.

Maintenance doses and the 15 mg maximum

The 7.5 mg and 12.5 mg strengths are generally used during dose escalation. The labeled maintenance doses for weight management are 5 mg, 10 mg, and 15 mg.

The maximum labeled Zepbound dose is 15 mg once weekly. Taking more is not a standard next step, and reaching the maximum is not the goal for everyone. Our tirzepatide 15 mg refill guide covers the information we recommend reviewing at this dose.

When should your Zepbound dose increase?

Titration means increasing a medicine in planned steps. With Zepbound, an increase may occur after at least four weeks at the current dose.

Four weeks is a minimum interval, not a monthly deadline. Before each change, we recommend reviewing:

  • Appetite and hunger changes
  • Weight trends over several weeks
  • Current and recent side effects
  • Time at the current dose
  • Missed or late injections
  • Treatment goals
  • Other medicines and health conditions

A higher number of milligrams does not guarantee a better result. It may increase side effects without resolving a temporary plateau. Never raise the dose, combine injections, or alter the schedule without a prescription.

When staying at the current dose may make sense

Remaining at a labeled maintenance dose may be reasonable when it controls appetite, supports progress, and remains tolerable. Someone taking 5 mg does not have to increase simply because another month has passed.

For example, appetite control may still be useful after six weeks at 5 mg, while constipation remains troublesome. An automatic increase could make that symptom harder to manage. The clinician may keep the dose steady while addressing side effects and reviewing the broader response.

Our guide to tirzepatide 5 mg dosing, plateaus, side effects, and refills explains this decision in more detail.

Does a weight-loss plateau mean the dose is too low?

Not necessarily. A couple of weigh-ins without a change do not prove that the dose has stopped working.

Before treating a plateau as a dosing problem, review:

  • Weight data across several weeks
  • Appetite and portion changes
  • Injection timing and missed doses
  • Time at the current strength
  • Constipation or fluid changes
  • Food, sleep, and activity patterns
  • Side effects that limit normal eating or activity

A longer trend gives the prescriber more useful information than a single number. Dose changes should reflect the full record.

What if treatment was interrupted?

There is no single restart plan for every extended interruption. Tolerance may change after time away from treatment, particularly if the previous dose caused gastrointestinal symptoms.

Contact the prescriber before restarting. Do not assume the old dose remains appropriate or create a catch-up schedule yourself.

Side effects can change the next-dose decision

Side effects can change the next-dose decision

Commonly reported Zepbound side effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, injection-site reactions, and fatigue. Gastrointestinal symptoms may appear or worsen following an increase.

Side effects are not proof that the medicine is working. They are information the prescriber needs. We recommend reporting them before a refill or increase so the clinician can maintain the dose, postpone an increase, or revise the plan when appropriate.

Do not reduce the dose or change the injection interval without clinical guidance. Our GLP-1 side-effect triage and refill decisions guide can help organize symptoms before contacting a clinician.

Signs the current dose needs clinical review

Contact the care team when symptoms:

  • Limit food or fluid intake
  • Return after each injection
  • Persist or become worse
  • Disrupt work, sleep, or daily activities
  • Intensify after a dose increase

Record the symptom, when it started, its severity, fluid intake, and the date of the last injection. Note vomiting, bowel changes, and any medicines used for relief. A clear record supports a more informed refill decision.

When to seek prompt medical help

Seek prompt care for severe or persistent abdominal pain, repeated vomiting, or possible dehydration, including confusion, faintness, very low urine output, or an inability to keep fluids down.

Trouble breathing or swelling of the face or throat may signal a severe allergic reaction and requires emergency help. Other serious concerns may include symptoms associated with pancreatitis, gallbladder problems, kidney injury, severe low blood sugar when Zepbound is combined with certain diabetes medicines, vision changes, or a neck mass. Do not send urgent symptoms through a routine refill request.

What to do after a missed Zepbound dose

Current prescribing instructions say to take a missed dose within four days of the scheduled time. If more than four days have passed, skip it and take the next dose on the usual day.

Do not take two doses less than three days apart. The regular injection day can generally be changed when at least three days separate the doses. If the timing is uncertain, confirm the plan with a pharmacist or prescriber.

The four-day rule in one example

Suppose the regular injection is due Monday morning:

  • Tuesday through early Friday: The missed dose is still within the four-day window.
  • After the four-day window: Skip the missed dose.
  • The following Monday: Return to the regular schedule.

Exact timing may matter near the end of the window. Rather than estimating, check with a pharmacist.

Changing your weekly injection day

A weekly injection day may be changed when at least three days pass between doses. For example, a person who injected on Monday morning could generally move the next dose to Thursday morning or later, provided that this fits the prescribed plan.

Do not use a schedule change to replace a dose that should be skipped. Never compress two doses into a shorter interval than the prescribing instructions allow.

Why there is no universal Zepbound dosage chart in units

Zepbound is prescribed in milligrams, which measure drug mass. Milliliters and syringe units measure volume.

A volume contains a specific number of milligrams only when the exact concentration is known. Two vials may contain different amounts of medicine in the same volume, so an identical syringe mark can represent different doses.

Insulin syringe units do not measure tirzepatide potency. For that reason, we do not recommend generic milligram-to-unit calculators or conversion charts.

Never copy directions from another product, concentration, device, or indication. This applies even when both products contain tirzepatide. Branded Zepbound and compounded products may use different presentations and measuring instructions. Review our compounded tirzepatide safety and dosing guide before changing sources.

Read these fields on the pharmacy label

Before injecting, confirm:

  • Product name
  • Prescribed strength in milligrams
  • Concentration, if supplied in a vial
  • Stated dose volume, when applicable
  • Device type
  • Injection day and frequency

A refill may arrive in a different presentation. Do not assume previous measuring directions still apply. If the label does not clearly connect the prescribed milligrams with the supplied device or volume, contact the pharmacy before injecting.

Do not split, combine, transfer, or click-count doses

Use the product exactly as its current Instructions for Use direct. Do not save partial doses, combine products, transfer medicine between containers, or count device clicks unless the approved instructions specifically require it.

If an uncertain amount has already been injected, contact the prescriber or dispensing pharmacist promptly. In the US, Poison Control can be reached at 1-800-222-1222. Call emergency services for trouble breathing, loss of consciousness, severe symptoms, or another immediate danger.

How to inject Zepbound in the thigh, abdomen, or upper arm

Zepbound is injected under the skin of the abdomen, thigh, or upper arm. Depending on the supplied device instructions, another person may need to give an upper-arm injection.

Rotate sites each week. Avoid skin that is tender, bruised, hard, scarred, or damaged. Changing the injection site does not change the prescribed milligram dose.

Because product presentations may vary, follow the Instructions for Use included with the exact pen or vial rather than relying on directions for another device.

Thigh injection checklist

For a thigh injection:

  • Use the area shown in the supplied Instructions for Use.
  • Check the skin for bruising, scarring, tenderness, or damage.
  • Clean the site and allow it to dry.
  • Follow the device instructions in order.
  • Avoid the exact point used for the previous injection.
  • Dispose of used sharps as directed.

Do not inject through clothing or touch the site after cleaning it.

Using Zepbound with insulin

Do not mix Zepbound and insulin in the same injection. If both medicines are injected in the same general body area, use separate sites.

Follow the clinician’s instructions for each medicine. Monitor glucose as directed because combining Zepbound with insulin or certain diabetes medicines may increase the risk of low blood sugar.

What to confirm before your next Zepbound refill

A useful refill request gives the clinician enough information to assess the next strength. We recommend gathering:

  • Last dose in milligrams
  • Date of the last injection
  • Number of weeks at that dose
  • Missed or late doses
  • Current side effects
  • Weight trend over several weeks
  • Appetite changes
  • Current product and strength
  • Pen, vial, or other presentation
  • Pharmacy and planned injection day

Confirm the exact product before the prescription is sent. When changing between branded Zepbound and another tirzepatide source, never assume that an old syringe mark applies to the new product.

Dose strength alone does not determine the cash price. Presentation, pharmacy pricing, supply, discount terms, and insurance coverage may all affect cost. Check the current price for the exact prescription.

A message to send your clinician

Use this refill template:

My last dose was [dose in mg] on [date]. I have taken this dose for [number] weeks and missed [number] doses. My current side effects are [symptoms]. My appetite has [changed/not changed], and my weight trend over the past several weeks is [trend]. I need my refill by [date].

Add the product, device, pharmacy, and preferred injection day. If the directions are unclear, send a legible pharmacy-label photo through a secure channel.

Do not wait for a routine refill if the dose may be wrong

Contact the dispensing pharmacist or prescriber before injecting if the label, concentration, device, or measured amount may be incorrect. Do not estimate.

A possible overdose or urgent symptom requires immediate guidance rather than a standard telehealth refill review. Contact Poison Control, urgent care, or emergency services as appropriate.

Zepbound dosing questions

What are the different doses of Zepbound?

Zepbound is available in six once-weekly strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, subject to current product availability.

The 2.5 mg strength starts treatment. The 7.5 mg and 12.5 mg strengths are escalation steps. For weight management, 5 mg, 10 mg, and 15 mg are labeled maintenance doses.

What is the highest dose of Zepbound?

The highest labeled dose is 15 mg once weekly. There is no standard step above it.

Not everyone needs to reach 15 mg. A lower maintenance dose may remain appropriate when it supports the treatment goal and stays tolerable.

What side effects can occur with Zepbound 5 mg?

Reported effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, fatigue, and injection-site reactions. Symptoms may emerge or change when moving from 2.5 mg to 5 mg.

Tolerance varies. Report persistent or limiting symptoms before the next refill.

Is Zepbound stronger than Wegovy?

Milligram numbers cannot answer this question. Zepbound contains tirzepatide, while Wegovy contains semaglutide. The medicines use different dosing scales, so a direct milligram comparison is misleading.

Treatment choice depends on the approved indication, health history, previous response, side effects, access, and clinical assessment.

FAQ

Must Zepbound increase every four weeks?

No. Four weeks is the minimum interval between increases, not a required deadline. The clinician should first review response, side effects, adherence, and treatment goals. Remaining at a labeled maintenance dose may be appropriate.

Can I restart my old dose after missing several weeks?

Do not restart automatically. An interruption may change how well the previous dose is tolerated. Tell the prescriber the last dose, last injection date, length of the interruption, and previous side effects.

Can I convert Zepbound milligrams into syringe units?

Only with the exact concentration and dispensing instructions. Milligrams measure drug mass, while syringe units indicate volume. If the pharmacy label does not provide clear directions, do not inject until the pharmacy confirms them.

Does changing the injection site change the dose?

No. The prescribed milligram dose stays the same whether Zepbound is injected under the skin of the thigh, abdomen, or upper arm. Rotate sites and follow the current Instructions for Use.

Does a short weight plateau mean I need a higher dose?

No. Review weight trends, appetite, injection timing, side effects, constipation, and time at the current dose. The prescriber can then decide whether to allow more time or adjust treatment.

Review your next dose before the refill is due

At usetemi.com, we help eligible patients complete online prescription and GLP-1 refill reviews. Send us the current dose, injection date, symptoms, appetite changes, weight trend, and product details before the next refill is due. Start your review today so a clinician can assess the dosing plan before your next injection.

Editorial Standards

This article has not been reviewed by a licensed physician. We cite peer-reviewed studies, academic research institutions, and medical associations. Our sources are listed at the end of each article.

If you notice an error or have a concern about our content, please email supportusetemi.com.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Felt Temigami re-enacting famous revolutions, from crossing the Delaware to raising a pill-bottle flag.

The revolution will be emailed.

Once a week, roughly. We're taking the fight to a corrupt and broken health insurance system. Join up.

Get Temi's newsletter by email. Unsubscribe anytime. Privacy policy

Temi

Start online, and a licensed physician reviews your request

See if you qualify

A licensed physician reviews every request. Nothing on this page is a prescription.